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A B S T R A C T   
Reactive oxygen species (ROS) are generated during physiological bouts of synaptic activity and as a conse-
quence of pathological conditions in the central nervous system. How neurons respond to and distinguish be-
tween ROS in these different contexts is currently unknown. In Drosophila mutants with enhanced JNK activity, 
lower levels of ROS are observed and these animals are resistant to both changes in ROS and changes in synapse 
morphology induced by oxidative stress. In wild type flies, disrupting JNK-AP-1 signalling perturbs redox ho-
meostasis suggesting JNK activity positively regulates neuronal antioxidant defense. We validated this hypoth-
esis in mammalian neurons, finding that JNK activity regulates the expression of the antioxidant gene Srxn-1, in a 
c-Jun dependent manner. We describe a conserved ‘adaptive’ role for neuronal JNK in the maintenance of redox 
homeostasis that is relevant to several neurodegenerative diseases.   
1. Introduction 
Active neurons generate reactive oxygen species (ROS) predomi-
nantly as a by-product of mitochondrial respiration. ROS levels are 
neutralized by constitutive and adaptive reductive mechanisms oper-
ating in neurons and glia, including the glutathione system [1–3]. In this 
manner, the amplitude and temporal dynamics of the ROS signal are 
controlled, damage is limited and transient ROS signals can be inter-
preted in part to support the growth and plasticity of neurons [4,5]. A 
physiological level of ROS has been demonstrated to regulate a range of 
nervous system processes, including neuronal development, synaptic 
plasticity, and neural circuit tuning [5–7]. 
In many neurodegenerative disorders the reductive capacity of 
neurons is overwhelmed, contributing to disease progression [4,8]. 
These damaging levels of ROS, termed oxidative stress, overwhelm 
neuronal antioxidant defenses. A central component of the neuronal 
response to ROS is the activation of c-Jun N-terminal kinase, JNK. ROS 
have been shown to activate JNK-AP-1 signalling [9] which regulates 
neuronal growth and plasticity [10–13]. In Drosophila models, excessive 
ROS driving increases in synaptic growth are seen in both activity 
generated excitotoxicity and lysosomal storage disease [5,12,14]. 
Similar changes in synaptic structure can be induced directly by 
application of oxidants such as paraquat [12] or diethylmaleate (DEM) 
[5], or through genetic activation of JNK via manipulation of the JNKK 
hemipterous [15] (hep) or the JNKKK Wallenda [11] (wnd), upstream 
activators of JNK. 
Whether JNK activation by ROS in neurons is protective or degen-
erative is unknown. Recent evidence indicates JNK-AP-1 activity can 
prevent degeneration of injured axons [16] while JNK inhibition pre-
vents neuronal loss after injury by promoting AKT signalling [17]. 
We recently found that knockdown of enzymes involved in antioxi-
dant defense, superoxide dismutase and catalase, reshapes neuronal 
morphology at the Drosophila larval neuromuscular junction (NMJ) [5]. 
Similarly, mis-expressing antioxidant enzymes to manipulate levels of 
individual ROS species has profound effects on synaptic and dendritic 
growth and arborisation [5,12]. This suggests that plasticity at the 
synapse is finely tuned to the level of ROS. Given that JNK is known to 
regulate synaptic plasticity in response to ROS and that knockdown of 
antioxidant genes can change synapse structure, we hypothesized that 
JNK-induced structural changes in neurons are mediated in part by an 
antioxidant response. 
To understand if JNK activity regulates antioxidant responses in 
neurons, we monitored ROS levels in Drosophila with mutations in 
highwire (hiw) and puckered (pucE69). In hiw mutants, unrestrained 
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wallenda (wnd) activity activates JNK and downstream AP-1 signalling 
to generate exuberant synaptic overgrowth [11,18]. Puc encodes a dual 
specificity phosphatase, transcriptionally activated by AP-1 that coun-
teracts JNK activity [19]. In both the hiw and pucE69/ + mutant back-
grounds we identified enhanced antioxidant defenses and low levels of 
ROS. In hiw, this enhanced antioxidant defense can be reversed in 
neurons by down-regulating JNK-AP-1 signalling. Conversely, both 
pucE69/ + and hiw flies are resistant to chemically induced oxidative 
stress, while inhibition of JNK-AP-1 signalling increases ROS levels in 
wild type neurons. We show that in mammalian neurons exposed to 
oxidative stress, the JNK-AP-1 pathway coordinates the transcription 
and translation of the antioxidant gene Sulfiredoxin-1, which was 
localised predominantly in synaptic compartments. Our data indicates 
that activation of JNK in neurons drives antioxidant responses to shape 
neuronal morphology. 
2. Results 
2.1. JNK activity drives antioxidant responses in Drosophila 
To quantify levels of ROS in Drosophila, we used the Amplex red 
assay for detection of hydrogen peroxide [20]. We have previously 
found that food containing 5 mM and 10 mM DEM which depletes 
glutathione levels, is sufficient to induce an overgrowth at the larval 
NMJ [5], with 10 mM concentrations being detrimental to survival 
(Fig. S1, 6% of flies pupate). To understand whether DEM influences 
ROS levels in flies, we raised flies on food containing ethanol (vehicle) or 
5 mM DEM. Using Amplex red we found that wild type flies have an 
increased ROS burden when raised on food containing 5 mM DEM 
(Fig. 1A). To investigate how JNK activity influences ROS levels under 
these conditions, we reared pucE69/+ and hiw mutants on the same food 
and found that both genotypes have significantly lower levels of ROS 
than wild type flies in vehicle-containing food. Moreover, both geno-
types failed to show an increase in ROS when reared on DEM-containing 
food (Fig. 1A) suggesting that they are resistant to the oxidative stress 
generated by DEM. 
Given that both pucE69/+ and hiw mutants have lower levels of ROS 
than wild type flies and are resistant to chemically-induced oxidative 
stress, we hypothesized that if JNK activity could be reduced in neurons 
of these flies, then ROS levels would increase back to wild type levels. To 
test this, we used hiw mutants and expressed dominant negative trans-
genes of jnk, wnd, ask1, jun and fos pan-neuronally using nSyb-Gal4 
(Fig. 1B). We found that pan-neuronal expression of these dominant 
negative transgenes increased ROS levels of hiw mutants back to wild 
type controls, except for ask1DN. This data indicates that manipulation of 
JNK, its upstream regulators and downstream targets, regulates ROS 
levels in neurons. 
To further evaluate the relationship between JNK activity and ROS 
levels, we investigated whether expression of dominant negative jnk, 
ask1 and wnd affects ROS levels in wild type flies. We found that 
expression of all dominant negative transgenes, pan-neuronally, signif-
icantly increases the ROS levels of wild type flies (Fig. 1C). Indeed, the 
levels observed were similar to those observed when wild type flies are 
reared on food containing DEM. 
The elaborate synaptic morphology of hiw mutant flies has been 
extensively described [11] and is a consequence of activation of the 
JNK-AP-1 pathway. We therefore chose to evaluate the synaptic 
morphology of pucE69/+ neurons by analyzing the NMJ at Muscle 6/7, 
hemi-segment A3. We first monitored the effect of DEM in wild type 
larvae, finding that wild type larvae fed with DEM develop an over-
grown NMJ, compared to larvae reared on normal food (Fig. 1D). 
Similar to hiw mutants, we found that pucE69/+ larvae have overgrown 
NMJ synapses (Fig. 1D). Feeding of DEM has no effect on the NMJ of 
pucE69/+ larvae, indicating that JNK activity alone is sufficient to 
change synaptic morphology, which correlates with an antioxidant 
response (decrease in ROS levels from Fig. 1A). Furthermore, the 
DEM-induced changes in synaptic morphology in wild type flies, can be 
rescued when dominant negative transgenes of jun, fos and ask1 are 
expressed pre- and post-synaptically using spinGAL4 (Fig. 1D, E). Our 
observations in Drosophila show that JNK activity regulates synaptic 
morphology but also antioxidant responses. In pucE69/+ and hiw flies, 
JNK-AP-1 signalling generates an antioxidant response which lowers the 
total levels of ROS in flies and protects them from induced oxidative 
stress while also causing an increase in NMJ synapse size. In wild type 
flies, inducing oxidative stress changes synaptic morphology, generates 
a stress response and these responses can be regulated by JNK (Fig. 1F). 
2.2. DEM induces oxidative stress in primary mammalian neurons 
JNK activity in mammalian neurons is often associated with 
apoptosis and activated JNK is commonly used as a hallmark of cell 
death in neurodegenerative disease. Given that JNK-AP-1 signalling in 
the fly generates an antioxidant response and decreasing JNK activity in 
fly neurons increases ROS levels, we hypothesized that antioxidant re-
sponses in mammalian neurons would also be regulated by JNK-AP-1. 
Having previously validated the effects of DEM in the fly, we estab-
lished a mammalian model of oxidative stress, using DEM to deplete 
cellular glutathione. We used this model to assay antioxidant responses 
after DEM treatment. We first characterized the effect of DEM on cellular 
GSH levels and ROS production in mature primary rat neurons, using a 
glutathione assay measuring total glutathione (oxidized and reduced 
forms). Fig. S2A shows that application of DEM to primary cortical 
neuronal cultures caused a concentration and time-dependent decrease 
in cellular glutathione. A 1 h and 4 h treatment of DEM at concentrations 
of 10 μM and 100 μM caused a rapid decrease in GSH (Fig. S2A). Lower 
concentrations of 1 μM DEM reduced cellular GSH content with less 
severity. Given the extent of GSH depletion by DEM, we investigated 
whether DEM induces mitochondrial toxicity by monitoring WST-1 
absorbance (Water Soluble Tetrazolium Salts) as a measure of mito-
chondrial stress. Compared to vehicle treated neurons, DEM induced a 
small but significant decrease in mitochondrial capacity, however this 
was much less than treatment with equivalent concentrations of para-
quat (PQ) and rotenone (RT) (Fig. S2B). To determine if DEM induces a 
ROS burden as it does in our fly model we measured H2O2 levels in 
neurons treated with DEM using Amplex red reagent. The Amplex red 
assay revealed that DEM (100 μM) significantly increased in H2O2 levels 
(Fig. S2C), after 24 h compared to ethanol treated controls (Fig. S2C). 
DEM-induced oxidative stress is significantly attenuated when neurons 
Fig. 1. JNK activity regulates neuronal antioxidant responses in Drosophila. A DEM induces oxidative stress in wild type flies but not puckered (pucE69/+) or 
highwire (hiw) mutants. Quantification of hydrogen peroxide levels (Amplex red fluorescence) in wild type, pucE69/+ or hiw mutant flies administered vehicle (0.16% 
ethanol) or DEM (5 mM). B Quantification of hydrogen peroxide levels in hiw mutants and hiw mutants pan-neuronally expressing dominant negative jnk (hiw; nSyb 
> bskR53K), wnd (hiw; nSyb > wndDN), ask1 (hiw; nSyb > ask1DN), jun (hiw; nSyb > junDN) and fos (hiw; nSyb > fosDN). C Quantification of hydrogen peroxide levels in 
wild type flies, pan-neuronally expressing dominant negative jnk (nSyb > bskR53K), wnd (nSyb > wndDN) and ask1 (nSyb > ask1DN). A-C Graphs show Amplex red 
fluorescence values normalized to the average signal of wild type flies. Data are plotted as mean ± SEM (**p < 0.01; ***p < 0.001; one-way ANOVA; minimum 15 
flies per genotype). D Representative micrographs showing synaptic overgrowth at the Drosophila third instar larval NMJ (Muscle 6/7, hemi-segment A3) in wild 
type, pucE69/+ mutants and wild type flies expressing dominant negative fos (fosDN), jun (junDN) and ask1 (ask1DN), reared on food containing ethanol or DEM. Scale 
bar = 30 μm. E Quantification of mean normalized bouton number from (D) genotypes. Data are plotted as mean ± SEM (***p < 0.001; one-way ANOVA; minimum 
15 NMJ’s analysed per genotype). F Schematic showing the contribution of JNK to neuronal antioxidant stress responses in Drosophila. (For interpretation of the 
references to color in this figure legend, the reader is referred to the Web version of this article.) 
C. Ugbode et al.                                                                                                                                                                                                                                 
Redox Biology 37 (2020) 101712
4
are pre-incubated with catalase. The duration and concentrations of 
DEM that we employed deplete glutathione and induce an increase in 
ROS with minimal toxicity to mitochondrial function. 
To model chronic oxidative stress, we treated neurons for longer time 
points (48 h) with DEM (100 μM) and found that DEM causes a retrac-
tion of the dendritic arbor. This effect is rescued when neurons are pre- 
incubated with Catalase (100 nM, Fig. S2D) and when the components 
that produce glutathione, the catalytic and modifying subunits of 
glutamate cysteine ligase (GCL), are transduced into neurons (Fig. S3). 
2.3. Oxidative stress activates JNK-dependent SRXN-1 expression, in 
primary mammalian neurons 
JNK enzymes are key mediators of cellular responses to stress in 
neurons [21], including oxidative stress [22,23], and alterations in JNK 
activity have previously been linked to changes in dendritic complexity 
[24]. Phosphorylation of threonine 183 and tyrosine 185 increase JNK 
activity [21]. To characterize the effectiveness of both DEM and the JNK 
inhibitor SU 3327 on regulating JNK phosphorylation and activation, we 
treated primary neurons with DEM (100 μM, 1 h) alone or in the pres-
ence of SU 3327 (700 nM, 1 h pre-treatment) and assayed JNK phos-
phorylation (Fig. 2A). We found a significant increase in 
phospho-JNK/total JNK ratios when neurons were treated with DEM, 
which was significantly attenuated when JNK activity was blocked with 
SU 3327 (Fig. 2 A,B). 
Bicuculline, a competitive antagonist of GABAA (γ-aminobutyric 
acid) receptors, and 4-aminopyridine, a voltage activated potassium 
channel blocker, are commonly used pharmacological tools that in-
crease neuronal activity in cultures of cortical neurons [25]. These tools 
have shown that increased neuronal activity can upregulate neuronal 
antioxidant genes, in an ERK-AP-1 dependent manner. A putative anti-
oxidant target gene of this signalling pathway, is Sulfiredoxin-1 (Srxn-1) 
[26]. To identify whether JNK-AP-1 signalling could regulate neuronal 
antioxidant genes, we compared our experiments with neurons treated 
with Bicuculline (Bic, 50 μM) and 4-Aminopyridine (4-AP, 500 μM) as a 
positive control (Bic/4AP). 
Using DEM, we found that JNK activity regulates Srxn-1 transcrip-
tion. DEM (10 μM) induced a 1.73-fold induction in Srxn-1 mRNA 
expression compared to the ethanol treated controls (Fig. 2C). Similar 
levels of Srxn-1 mRNA were observed at higher concentrations of DEM 
(Fig. S4C). When neurons were pre-treated with the JNK inhibitor SU 
3327 for 24 h, DEM failed to induce Srxn-1 mRNA. Similar to DEM 
treatment, increasing neuronal activity with Bic/4AP increased Srxn-1 
mRNA (1.32-fold), however this induction was unaffected by JNK in-
hibition. Synaptic activity is known to induce expression of c-Fos, an AP- 
1 component. We determined whether oxidative stress also induced c- 
Fos transcription. Fig. 2D shows that there was no change in c-Fos mRNA 
levels with DEM treatment whereas Bic/4AP treatment robustly induced 
c-Fos transcription. Similar to activity-induced Srxn-1 induction, c-Fos 
induction by synaptic activity was unaffected by inhibition of JNK 
(Fig. 2D) suggesting that synaptic activity and oxidative stress recruit 
signalling pathways differentially to activate potentially divergent gene 
transcription responses. 
We next evaluated whether JNK activity regulates SRXN-1 protein 
Fig. 2. ROS induced JNK phosphorylation triggers neuronal antioxidant responses. A Representative Western blot of neurons treated with Bicuculline (50 μM, 
Bic) and 4-Aminopyridine (500 μM, 4AP) to increase synaptic activity (Bic/4AP) or DEM (100 μM) for 1 h, to induce oxidative stress. JNK activity was inhibited by a 
1 h pre-treatment with SU-3327 (SU, 700 nM). B Quantification of total phospho-JNK/pan-JNK ratios (*p < 0.05; **p < 0.01; one-way ANOVA; n = 3 biological 
replicates). C, D The mRNA levels of Srxn-1 and c-Fos were determined using quantitative PCR (qPCR) and were normalized to Gapdh mRNA levels. mRNA levels are 
expressed relative to untreated controls and shown as means ± SEM (*p < 0.05; **p < 0.01; unpaired t-Test; n = 4 biological replicates) C Srxn-1 mRNA is induced by 
oxidative stress in a JNK dependent manner. D JNK signalling downstream of oxidative stress does not require c-Fos. E JNK regulates SRXN-1 expression under 
oxidative stress but not during synaptic activity. Representative Western blot probed for SRXN-1, Pan-JNK, phospho-JNK, Pan-ERK, phospho-ERK and GAPDH 
antibodies. Neurons were treated with Bic/4AP (50/500 μM) or DEM (100 μM) in the presence or absence of either the JNK inhibitor SU 3327 (700 nM) or the NMDA 
receptor blocker MK801 (10 μM) for 30 min (lanes 2/4/6) or 4 h (lanes 3/5/7/8/9). 
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expression. Fig. 2E shows that treatment of neurons with DEM (100 μM) 
rapidly increased SRXN-1 protein expression within 30 min, with high 
levels detected at 4 h as assessed by Western blot using an antibody that 
we first validated by overexpressing human SRXN-1 in HEK293T cells 
(Fig S4A). DEM-induced SRXN-1 expression was attenuated when neu-
rons were pre-treated with SU 3327 (700 nM, 1 h pre-incubation). As 
expected, and in agreement with previous work [26], synaptic activity 
also induced SRXN-1 expression after a 4 h treatment with Bic/4AP, 
which was attenuated when neurons were pre-treated for 1 h with the 
non-competitive NMDA receptor antagonist MK801 (10 μM) but was 
unaffected by JNK inhibition. Moreover, synaptic activity but not DEM, 
induced ERK activation (Fig. 2E). Taken together, these data indicate 
that oxidative stress activates JNK to coordinate an antioxidant response 
in neurons, which is distinct from antioxidant responses coordinated by 
synaptic activity. 
2.4. JNK-c-Jun signalling regulates antioxidant responses in mammalian 
neurons 
To identify the cellular mediators that co-ordinate SRXN-1 expres-
sion under conditions of synaptic activity or oxidative stress, we assessed 
the expression and interaction of putative AP-1 components under the 
two conditions. Cortical neurons were treated with Bic/4AP or DEM for 
1 or 4 h and c-Fos or c-Jun immunofluorescence was quantified in NeuN 
positive neurons. In neurons treated with DEM (Fig. 3A and B) c-Fos 
immunofluorescence was found to decrease. In contrast, DEM induced a 
significant increase in c-Jun immunofluorescence. As expected, in neu-
rons stimulated with Bic/4AP for 1 or 4 h, both c-Fos and c-Jun 
immunofluorescence was found to increase (Figs. S4, B,D). These data 
suggest that oxidative stress relies on Jun proteins to mount an antiox-
idant response in the absence of c-Fos. To further investigate the dif-
ferential involvement of specific AP-1 components we 
immunoprecipitated c-Jun from cortical neurons treated for 1 h with 
either DEM or Bic/4AP and assessed its phosphorylation and association 
with c-Fos protein. While both DEM and Bic/4AP induce c-Jun expres-
sion and phosphorylation, c-Jun co-immunoprecipitated with c-Fos 
following Bic/4AP-induced synaptic activity but not during oxidative 
stress mediated by DEM (Fig. 3C). In mammals, c-Jun can form heter-
odimers with other members of the Jun family to form the dimeric AP-1 
transcription factor. To identify if c-Jun was associated with another Jun 
family member, we probed membranes for JunB and JunD and found no 
association between either protein with c-Jun in DEM-treated neurons 
(Fig. S4E). To determine whether c-Jun alone is sufficient to induce 
SRXN-1 expression, lentiviral particles encoding human c-Jun (Fig. 3D) 
were transduced into cortical neurons. Lentiviral c-Jun expression was 
sufficient to induce SRXN-1 expression in neurons (Fig. 3E), however 
activation of Nuclear Factor Erythroid 2-related factor 2 (Nrf2) using the 
well characterized agonist TBHQ (10 μM, 16 h) had no effect on 
neuronal expression of SRXN-1. Taken together, these data suggest that 
oxidative stress activates JNK, which selectively recruits c-Jun to induce 
Fig. 3. JNK Recruits c-Jun for SRXN-1 expression. 
A, B Oxidative stress reduces c-Fos and increases c-Jun. Representative images showing c-Fos (top panels) and c-Jun (bottom panels) immunoreactivity in neurons 
left untreated (Control) or treated for 1 h with 100 μM DEM. Neurons were co-stained for the neuronal marker NeuN and nuclei were labelled with DAPI. B 
Quantification of immunoreactivity in A, of neurons stimulated for 1 h or 4 h with 100 μM DEM. Data are plotted as mean ± SEM. Analysis represents NeuN positive 
neurons. c-Fos levels were assessed in 118 neurons and c-Jun immunoreactivity was quantified in 81 neurons across 3 biological replicates (**p < 0.01; ***p < 0.001 
one-way ANOVA followed by a Dunnett’s post-hoc test). Scale bar = 25 μm. C Representative Western blot of neuronal lysates immunoprecipitated with a c-Jun 
antibody in conditions of synaptic activity (Bic/4AP) or oxidative stress (DEM 100 μM) in the presence or absence the JNK inhibitor SU 3327 (700 nM, 1 h). D 
Representative images of c-Jun immunofluorescence in HEK293T cells transduced with lentivirus encoding empty vector, or pLenti c-Jun. Scale bar = 25 μm. E 
Western blot showing c-Jun, GAPDH and SRXN-1 levels in neurons transduced with lentivirus containing empty vector (1) or c-Jun (3) overnight, or treated with the 
Nrf2 agonist, tert-Butylhydroquinone (TBHQ, 10 μM, 4) overnight. HEK293T cells transduced with pLenti c-Jun (2) were run as a positive control. F A schematic 
demonstrating JNK and c-Jun dependent regulation of SRXN-1 during oxidative stress. 
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SRXN-1 expression in neurons (Fig. 3F). 
2.5. SRXN-1 is localised at synaptic terminals and prevents dendrite loss 
To understand how SRXN-1 contributes to neuronal antioxidant 
defenses we investigated SRXN-1 localization in neurons. Having pre-
viously identified that chronic treatment of cortical neurons with DEM 
causes a loss of dendrites, we transfected neurons with PSD95-GFP alone 
or in combination with a plasmid encoding N-terminal FLAG-tagged 
human SRXN-1 and treated cells with DEM (48 h). We found that 
overexpression of SRXN-1 prevented dendrite loss caused by long-term 
treatment of DEM (Fig. 4A). Interestingly, we also observed overex-
pressed SRXN-1 immunoreactivity in distal dendrites and on closer ex-
amination found that overexpressed SRXN-1 was localised to dendrites 
and dendritic spines (Fig. 4B). SRXN-1 co-localised with PSD-95-GFP, as 
indicated by white arrowheads in Fig. 4B. 
To further investigate the synaptic localization of SRXN-1, we 
assessed its distribution in subcellular fractions of mouse brain using the 
antibody validated in heterologous cells (Fig. S4A). Although charac-
terized as a cytoplasmic enzyme [27], SRXN-1 was not observed in the 
synaptic supernatant fractions, but in the LP1 (synaptosomal) and LP2 
(synaptic vesicle) membrane fractions. The efficacy of the fractionation 
was confirmed by enrichment of the transcription factor FOXO3a in 
supernatant fractions over the pellet fractions. The P2 fraction repre-
sents a crude synaptosomal fraction comprising microsomes and isolated 
pre- and post-synaptic nerve terminals. SRXN-1 was most enriched in the 
LP1 fraction, indicative of synaptic membranes and small organelles, 
such as mitochondria. Immunoblotting for the alpha subunit of the 
mitochondrial F1 ATP synthase (ATP5A1) confirmed the presence of 
mitochondrial proteins in the LP1 fraction. SRXN-1 immunoreactivity 
Fig. 4. SRXN-1 localises to synaptic terminals in rodent neurons and rescues DEM induced retraction 
A SRXN-1 overexpression rescues DEM-induced dendritic retraction. Representative micrographs of mature neurons transfected with PSD95-GFP constructs alone 
(left panels) or in combination with Flag-tagged human SRXN-1 (right panels) ± 100 μM DEM (48hr). Cells stained with anti-GFP (green), anti SRXN-1 (Flag 
antibody, red) and nuclear staining with DAPI (blue). Scale bar = 100 μm. B Overexpressed human SRXN-1 co-localises with PSD95-GFP in dendritic spines. 
Representative images show an overlay of GFP and Flag immunofluorescence. Magnified images of dendritic spines outlined in white boxes (PSD95-GFP + SRXN-1, 
scale bar = 5 μm). C Endogenous SRXN-1 protein is present at synapses. Representative Western blot of synaptosome fractions prepared from mouse brain, probed 
with antibodies for the nuclear protein FOXO3a, the pre-synaptic marker synapsin 1 (Syn1), the mitochondrial protein ATP5A1, JNK and SRXN-1 as indicated. D 
Schematic representation of likely signalling pathways mediating Srxn-1 transcriptional induction in response to synaptic activity and oxidative stress. (For inter-
pretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
C. Ugbode et al.                                                                                                                                                                                                                                 
Redox Biology 37 (2020) 101712
7
was also present in the LP2 fraction, which is enriched in synaptic ves-
icles (SV), as shown by an enrichment of the SV protein synapsin I 
(Fig. 4C). JNK immunoreactivity was observed in all fractions, but was 
enriched in P2, LP1 and LP2, in-line with the distribution of SRXN-1. 
These data suggest that SRXN-1 associates with synaptic membranes 
and is consistent with the co-localization with PSD95 we observed by 
fluorescence microscopy. Therefore, in neurons, antioxidant proteins 
such as SRXN-1 and sensors of oxidative stress such as JNK are located at 
synapses, placing them at functionally important sites to orchestrate the 
adaptive antioxidant response (Fig. 4D). 
3. Discussion 
Here we have uncovered a role for JNK signalling in the regulation of 
neuronal antioxidant capacity using Drosophila and mammalian neurons 
in culture. We and others have shown previously that JNK regulates 
changes in synaptic morphology independently of any stimuli [11] or in 
response to ROS [5,12,14]. We now show that JNK activation drives an 
antioxidant response, which shapes cellular reductive capacity and 
synaptic morphology. 
We show that Drosophila mutants that have enhanced JNK activity 
have low levels of ROS and furthermore, are resistant to chemically 
induced oxidative stress. These reduced ROS levels in mutant flies can be 
reinstated back to levels observed in wild type flies by inhibiting the 
JNK-AP-1 pathway. In addition to changes in ROS levels, we show that 
activation of the JNK-AP-1 pathway leads to overgrown synapses at the 
Drosophila NMJ suggesting that the status of JNK signalling has impli-
cations for structural synaptic plasticity. In mammalian cortical neurons 
we identified an ‘adaptive’ JNK-dependent antioxidant response when 
neurons are challenged with oxidative stress. This adaptive response 
relies on JNK’s downstream effector c-Jun, and results in increased 
abundance of the antioxidant protein SRXN-1. In contrast, JNK- 
independent SRXN-1 expression is triggered with increased synaptic 
activity of cortical neurons. We therefore implicate JNK signalling in the 
regulation of neuronal antioxidant defenses and identify distinct dif-
ferences in neuronal responses to ROS generated in conditions of syn-
aptic activity and oxidative stress. 
3.1. Constitutive JNK activation drives an antioxidant response in 
Drosophila 
Genetic and pharmacological activation of JNK changes neuronal 
morphology and this structural change is dependent on AP-1 [15,28]. 
JNK-AP-1 signalling has long been known to positively regulate growth 
and strength at the larval NMJ [15]. JNK has also been shown to mediate 
the effect of ROS generated during oxidative stress associated with 
excitotoxicity [14] and lysosomal storage disease [12]. Combined with 
reports that activation of the JNK pathway after neuronal injury co-
ordinates a regenerative response [16] and that AP-1 signalling regu-
lates dendrite growth during both development and during conditions of 
synaptic activity; JNK-AP-1 signalling has been demonstrated as a 
crucial regulator of neuronal homeostasis. Both pucE69/+ heterozygotes 
and hiw mutants, which have increased JNK activity [11,19], showed 
reduced total ROS levels and rendered flies resistant to chemically 
induced oxidative stress. The reduced ROS levels in pucE69/+ hetero-
zygotes and hiw mutants flies could be reversed by inhibition of neuronal 
JNK-AP-1, suggesting that the altered ROS originates from neurons. The 
reduced total ROS levels, arising from protective JNK signalling, in hiw 
mutants might explain the recently reported resistance of neurons in 
highwire null flies to the damaging effects of physical blows, which 
mimic traumatic brain injury [29]. 
A key question raised by our work is whether the JNK-dependent 
changes in synaptic morphology are driven by the increased antioxi-
dant defenses. We have previously identified DEM as a regulator of 
neuronal morphology at the NMJ [5] and here we show that this 
DEM-induced change in synaptic morphology is regulated by JNK. 
Furthermore, we show that pucE69/+ larvae have overgrown NMJ’s 
which are not influenced by oxidative stress induced by DEM. Given that 
pucE69/+ and hiw larvae have elevated JNK activity, reduced ROS, 
elaborate NMJ’s and are resistant to chemically induced oxidative stress, 
our data suggests that changes in neuronal plasticity in these models is at 
least, in part, driven by an antioxidant response. 
3.2. JNK coordinates antioxidant responses in mammalian neurons 
It is known that synaptic activity can regulate the expression of 
neuronal antioxidant genes [26]. Furthermore, we have recently shown 
that ROS generated from synaptic activity acts as a signalling molecule 
to regulate neuronal plasticity, in a PI3K/DJ-1β dependent manner [5] 
implicating synaptic activity and ROS in the regulation of synaptic 
plasticity. What is currently unknown is how neurons recognize and 
respond to differences in physiological and pathological ROS. Our data 
shows that neurons recruit different signalling pathways to mediate ROS 
generated by synaptic activity or oxidative stress, but converge to 
regulate the same antioxidant gene, Srxn-1. 
Increasing synaptic activity activates ERK1/2 [30,31] that can in 
turn phosphorylate AP-1 components [32,33]. Consistent with this, we 
found that increasing neuronal activity using Bicuculline and 4-AP 
regulates Srxn-1 mRNA and protein expression [26]. Conversely, 
inducing oxidative stress in neurons with DEM did not affect ERK 
phosphorylation of AP-1 but did activate JNK and SRXN-1 expression. 
JNK inhibition abolished increased SRXN-1 in conditions of oxidative 
stress but not during synaptic activity. This suggests that neurons use 
distinct kinases to upregulate SRXN-1 expression in response to synaptic 
activity or oxidative stress. 
Synaptic activity has been demonstrated to boost glutathione syn-
thesis, providing a positive feedback loop, where accumulating levels of 
ROS from increased synaptic activity are neutralized by increases in 
cellular glutathione [26]. JNK activity is also regulated by cellular 
glutathione levels. In non-stressed cells, JNK is tethered to monomeric 
glutathione S-transferase Pi (GST-Pi) and increased H2O2 can trigger the 
detachment and oligomerization of GST-Pi, conjugating ROS to gluta-
thione [34]. This suggests that JNK activity is tuned to the redox 
thresholds of the cell [35]. This is important given that glutathione 
homeostasis is altered in many neurodegenerative diseases [60,61] and 
decreased glutathione levels have been observed in mouse models of 
Alzheimer’s Disease [62] and in AD patients [63]. 
Both ERK1/2 and JNK kinases regulate AP-1 [21,32], raising the 
possibility that the mechanisms converge at the level of this dimeric 
transcription factor. The AP-1 heterodimer of c-Fos and c-Jun [36] is 
well characterized but the conditions driving differential heterodimer 
composition are not well understood. In our work, a notable difference 
between synaptic activity and oxidative stress conditions was the lack of 
c-Fos transcriptional/translational induction by DEM and reduced 
dimerization with c-Jun. This indicates that DEM-induced AP-1 activity 
and Srxn1 transcription is c-Fos independent (Fig. 4C and D). The 
mammalian AP-1 complex can contain Fos, Jun, Fra, and ATF compo-
nents and multiple hetero- and homo-dimeric partners are capable of 
binding to AP-1 DNA binding sites [37,38]. Our immunoprecipitation of 
c-Jun showed a clear association with c-Fos during conditions of 
increased neuronal activity, but this association was absent during 
conditions of oxidative stress. Moreover, total c-Jun increased during 
oxidative stress and we did not detect JunB or JunD in immunoprecip-
itates suggesting that c-Jun may homodimerise to generate an antioxi-
dant response in neurons. Our data identify a clear divergence between 
physiological and stress-dependent signalling in neurons, where acti-
vation of JNK and lack of c-Fos defines the stress response. 
3.3. SRXN-1 is present at the synapse 
SRXN-1 is an oxidoreductase that reduces sulfinylated proteins such 
as 2-cys peroxiredoxins (PRDX), small redox sensitive proteins widely 
C. Ugbode et al.                                                                                                                                                                                                                                 
Redox Biology 37 (2020) 101712
8
expressed in mammalian neurons [39]. Both cysteine residues in PRDX 
can undergo reversible hyper-oxidation by peroxides to form sulfinic 
acid (Cys-SO2H) [40]. Hyper-oxidation of PRDX proteins inactivates 
their peroxidase activity. This inactivation is known to occur in neurons 
where it can be seen to follow a circadian time course [41], and occur 
during glutamate induced excitotoxicity [42] in addition to oxidative 
stress conditions [43]. SRXN-1 catalyses the reduction of Cys-SO2H in an 
ATP dependent manner, restoring PRDX activity [44]. Both PRDX and 
SRXN-1 are regulated by synaptic activity [26]. Our data indicate that 
the cellular levels of SRXN-1 can also be tuned by the intracellular 
concentration of GSH and H2O2 levels. 
We additionally show that SRXN-1 can be found at cellular locations 
that are particularly vulnerable to ROS - synaptic terminals and den-
drites [45]. Overexpressed human SRXN-1 localised to dendrites and 
dendritic spines and endogenous SRXN-1 protein was particularly 
enriched in synaptosomal membrane fractions. We also found that JNK 
kinases were present in synaptosomes. The localization of SRXN-1, a 
cytosolic protein, in a synaptic membrane fraction is intriguing. How-
ever, in non-neuronal cells, SRXN-1 has been reported to translocate 
from the cytosol to a ‘heavy membrane’ fraction enriched in mito-
chondria in response to oxidative stress [46]. Mitochondrial SRXN-1 has 
a role in re-activation of oxidized peroxiredoxins [40,47] and our data 
indicate that SRXN-1 might reside constitutively with neuronal mito-
chondria, consistent with a greater basal ROS burden in neurons. 
Taken together, our data from both fly and mammalian models 
identify a fundamental conserved role of JNK signalling in regulating 
neuronal redox homeostasis through an adaptive antioxidant response. 
JNK signalling is activated specifically by oxidative stress and activates 
c-Jun containing AP-1 transcription factors independently of c-Fos. In 
this manner, JNK imparts mechanistic specificity to activate AP-1 under 
conditions that have relevance to a number of neurodegenerative 
diseases. 
4. Materials and methods 
4.1. Culture of neurons and cell lines 
Timed-mated female Wistar rats (Charles River UK) (RRID: 
RGD_737929) were maintained in accordance with the UK Animals 
(Scientific Procedures) Act (1986). Cortices were dissected from post-
natal day 1 (P1) mixed sex rat pups. Animals were euthanised using 
pentobarbital injection followed by cervical dislocation, according to 
Home Office guidelines. Cortical cell suspensions were obtained as 
previously described and cytosine arabinoside (AraC, 2.4 μM final 
concentration) was added to the growth medium at 1 day in vitro (DIV) 
[48]. 
Neurons were transfected at 12 DIV with PSD95-GFP (a kind gift 
from David Bredt [49] and FLAG-tagged Human SRXN-1 (purchased 
from Origene: RC207654) for 5 h using Lipofectamine 2000 (11668019, 
Thermo Scientific). Experiments were performed in a defined culture 
medium (Transfection medium (TM) contains: 90 ml SGG; 114 mM 
NaCl, 26.1 mM NaHCO3, 5.3 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM 
HEPES, 1 mM glycine, 30 mM glucose, 0.5 mM C3H3NaO3 and 10 ml 
MEM (51200046, Thermo Scientific) supplemented with 100x ITS (1x 
final concentration; insulin/transferrin/selenium, 41400045, Thermo 
Scientific), penicillin (50 U/ml) and streptomycin (50 μg/ml)). After 24 
h incubation in TM, cells were treated with DEM, bicuculline, catalase, 
paraquat, rotenone, 4-Aminopyridine or SU 3327 at concentrations and 
durations stated in the figure legends. 
HEK293-FT (RRID:CVCL_6911, Thermo Scientific) cells were grown 
in DMEM containing 10% FBS. Cells were passaged and at 60% con-
fluency, transfected with 10 μg of either pCMV entry vector (empty) or 
pCMV Human SRXN-1. After 3 days, cells were lysed as described below. 
4.2. Lentiviral preparation 
Lentiviruses were prepared using the 2nd generation system. Pack-
aging plasmids were produced by the Trono lab (psPAX2 and pMD2.G 
were gifts from Didier Trono (Addgene plasmid #12260; http://n2t. 
net/addgene:12260; RRID:Addgene_12260 and Addgene plasmid 
#12259; http://n2t.net/addgene:12259; RRID:Addgene_12259). pLenti 
c-Jun was created by cloning human c-Jun from PMIEG3-c-Jun (a gift 
from Alexander Dent (Addgene plasmid #40348) [50] using BAMHI and 
XHOI into pLenti-puro (a gift from Ie-Ming Shih (Addgene plasmid 
#39481; http://n2t.net/addgene:39481; RRID:Addgene_39481)) [51]. 
Viral particles were generated and transduced as described previously 
[52]. 
4.3. Hydrogen peroxide assay 
Experiments were performed in phenol red free TM. TM containing 
50 μM Amplex Red reagent and 0.1 U/ml HRP was added to neurons in 
12 well dishes (500 μl per well) for 15 min after which cells were treated 
with different concentrations of DEM, or catalase. Fluorescence at 590 
nm was measured periodically and compared against a H2O2 standard 
curve for quantification. For fly experiments, Amplex red reagent was 
made up in Hemolymph solution (HL3) containing NaCl (128 mM), KCl 
(2 mM), CaCl2.2H2O (1.8 mM) MgCl2.6H2O (4 mM), HEPES (5 mM) and 
sucrose (35.5 mM) at pH 7.2. Each fly was crushed in 250 μl of Amplex 
red reagent using a pestle, vortexed and left at 25 ◦C, in the dark for 90 
min. After 90 min, all samples were spun down for 1 min and each 
biological replicate was read in duplicate. Only males were used for 
amplex red assays to avoid issues with dosage compensation. 
4.4. WST-1 assay 
After treatment, primary rat neurons were washed with TM and then 
incubated with phenol red free TM containing WST-1 reagent (Sigma, 
Cat# 5015944001, 20 μl/ml) for 4 h at 37 ◦C. 200 μl was transferred to a 
96 well plate and absorbance measured using a plate reader (BMG 
Fluostar λ = 440 nm). 
4.5. Immunocytochemistry 
Cells were washed with phosphate buffered saline (PBS) and fixed for 
30 min at room temperature with 4% paraformaldehyde (containing 4% 
sucrose; Sigma). Cells were permeabilized in 0.5% NP40 in PBS for 5 
min at room temperature. All primary and secondary antibodies, di-
lutions and suppliers can be found in Table 1. Primary antibodies were 
incubated overnight at 4 ◦C. Corresponding Alexafluor secondary anti-
bodies (1:500, Thermo Scientific) were incubated for 1 h at room tem-
perature before mounting with Fluoromount (Sigma). 
4.6. Microscopy and image analysis 
Images were collected on an inverted Zeiss microscope (880) with 
20x or 63x Plan Apochromat objectives using Zeiss filter sets for DAPI 
and Alexa 488, 546 or 633. Images were taken at a resolution of 2048 ×
2048 pixels. 
4.7. Synaptosome preparation 
The subcellular fractionation of mouse brain was performed as pre-
viously described [53]. Briefly, seven mixed sex mouse forebrains were 
dissected and transferred into cold homogenization buffer (320 mM 
sucrose, 1 mM EDTA, 5 mM Tris, pH 7.4, 4 ◦C), homogenized in a glass 
Teflon homogenizer, and centrifuged in an SS-34 rotor (1000g, 10 min, 
4 ◦C). The supernatant (S1) was collected and the pellet re-suspended in 
15 ml of homogenization buffer and centrifuged again (1000g for 10 
min). S1 supernatants were combined, and pellets (P1) collected. S1 
C. Ugbode et al.                                                                                                                                                                                                                                 
Redox Biology 37 (2020) 101712
9
lysates were further centrifuged at 13000g for 20 min at 4 ◦C. Super-
natant (S2) was collected and the pellet (P2) re-suspended in 21 ml 
homogenization buffer. The P2 pellet was further centrifuged at 13000g 
for 20 min at 4 ◦C. P2 was re-suspended in 320 mM sucrose (300 
μl/forebrain), transferred into a glass-Teflon homogenizer with 9 vol of 
ice-cold distilled water and immediately homogenized for 3 up/down 
strokes at 2000 rpm. Homogenates were incubated on ice for 30 min 
with 0.1 volume of 1 M HEPES-NaOH (pH 7.4) and centrifuged at 
25000g for 20 min at 4 ◦C. Pellets (LP1, synaptosomal membranes) were 
collected and the supernatant (LS1) further centrifuged in a 70 Ti rotor 
at 165,000g for 2 h at 4 ◦C. The resulting supernatant (LS2) was collected 
and the pellet (LP2, synaptic vesicles) re-suspended in 40 mM sucrose (2 
ml). Protein concentration was assayed using Bradford reagent and 20 
μg of each fraction was prepared in 1x Laemmli buffer for western 
blotting. 
4.8. Western blotting 
Cells were lysed in RIPA containing phosSTOP phosphatase in-
hibitors (4906845001, Roche) and complete EDTA-free protease in-
hibitors (04693132001, Roche) as previously described [54]. Lysates 
were run on Novex pre-cast mini gels (NuPAGE 4–12% Bis-Tris Gels, 
NP0322BOX, Thermo Scientific) in either 1 x MES or 1 x MOPS buffer. 
Antibodies used for immunoblotting are detailed in Table 1. 
4.9. Co-immunoprecipitation 
Neurons in 10 cm dishes were lysed as described. Lysates were 
incubated with primary antibodies for c-Jun at a 1:50 dilution and 
rotated overnight at 4 ◦C. Lysates were incubated with 15 μl (30 μl bead 
slurry) Protein G, Sepharose (GE Healthcare, 17-0618-01) for 2 h at 4 ◦C 
rotating. Samples were spun down, transferred to spin-x columns 
(Sigma, CLS8163-100 EA), washed 3 times with lysis buffer and the 
beads finally incubated with 4 x Laemmli (containing mercaptoethanol) 
for 10 min, then eluted through the spin columns. Samples were further 
heated at 95 ◦C for 5 min before western blotting. Proteins were detected 
using conformation specific antibodies (Cell Signalling, L27A9, mAb 
#3678) which prevent detection of heavy and light antibody chains. 
4.10. Glutathione assay 
Total levels of glutathione were assayed using a colorimetric Gluta-
thione Assay Kit (CS0260, Sigma). Briefly, at 14 DIV, primary neurons in 
35 mm dishes were treated with DEM in transfection medium for 1, 4 
and 24 h. Cells were then washed with PBS (4 ◦C), lysed with 5% sul-
fosalicylic acid and snap frozen in liquid nitrogen. Lysates were then 
defrosted at 37 ◦C, centrifuged at 10,000g for 10 min and 10 μl samples 
were used for the glutathione assay in accordance with the manufac-
turer’s instructions. 
4.11. Quantitative PCR 
Real-time quantitative PCR on the resulting cDNA was performed 
using a Fast SYBR Green Master mix (Applied Biosystems, 4385612) and 
gene specific primers. Relative expression of genes was determined by 
the 2-ΔΔCT method and Gapdh for normalization. Primers used were: 
Gapdh forward: 5′-AAACCCATCACCATCTTCCA-3′ and Gapdh reverse: 
5′- GTGGTTCACACCCATCACAA-3’; c-Fos forward: 5′- AGAATCC-
GAAGGGAAAGGAA-3′ and c-Fos reverse: 5′- ATTGAGAA-
GAGGCAGGGTGA-3’; Srxn1 forward: 5′-GACGTCCTCTGGATCAAAG-3′
and Srxn1 reverse: 5′-GCAGGAATGGTCTCTCTCTG-3’. 
4.12. Drosophila stocks and husbandry 
Drosophila were raised on 4–24® instant Drosophila medium (Car-
olina Biological Supply Company, USA) supplemented with a yeast 
Table 1 
Antibodies used in this study.  
Name Supplier Dilution Species RRID 




Anti- Synapsin 1 MERCK 1:1000 Rabbit RRID: 
AB_2200400 
Anti- GCLC SCBT 1:500 Mouse RRID: 
AB_2736837 
























Anti- FLAG Sigma 1:1000 Mouse RRID: 
AB_259529 
Anti- FLAG Cell Signalling 
Technology 
1:1000 Rabbit RRID: 
AB_2217020 









































































Sweeney Lab 1:2000 Rabbit RRID: 
AB_2713991 
Secondary Ab’s 
Gt anti Ms Alexa 
488 
Life Technologies 1:500 Goat RRID: 
AB_2576217 
Gt anti Rb Alexa 
546 
Life Technologies 1:500 Goat RRID: 
AB_10563566 
Gt anti Ms Alexa 
546 
Life Technologies 1:500 Goat RRID: 
AB_2534071 
Gt anti Rb Alexa 
488 










































1:200 Goat RRID: 
AB_2337972 
(continued on next page) 
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sucrose solution (5% w/v inactivated yeast, 10% w/v sucrose in ddH2O, 
100 g/500 ml) and maintained at 25 ◦C on a 12 h light:dark cycle. Prior 
to mixing with 4–24® instant media, vehicle (Ethanol) and DEM were 
added at the desired concentration (Ethanol 0.16%, DEM 0–10 mM). 
The following stocks were obtained from Bloomington Drosophila stock 
center: Canton-S (CS), w1118, UAS-bskK53R (#9311), UAS-fosDN (#7214), 
UAS-junDN (#7217), Act5C-Gal4 (Actin-Gal4), nSyb-Gal4. UAS- 
ask1K618M (ask1DN) was a kind gift from Masayuki Miura [55]. 
UAS-wndDN (wndKD) and hiwND9 were kind gifts from Aaron DiAntonio 
[11,56]. pucE69/TM6b flies were obtained from Alfonso Martinez-Arias 
[57]. SpinGal4/TM6b was obtained from Daisuke Yamamoto [58]. The 
JNK dominant negative (bskK53R) [59] and the highwire mutant (hiwND9) 
have been described previously [18]. All analyses were performed in 
males. hiwND9 females were crosses to Canton-S males to produce male 
hiwND9 animals in an outcrossed background. For hiwND9 crosses with 
dominant negative transgenes, hiwND9; nsyb-Gal4 females were crossed 
with males carrying the UAS transgenes. All wild types were an outcross 
of Canton S to w1118. 
4.13. Survival analysis 
Hatched 1st instar larvae were collected and raised in standard food 
with different DEM concentrations (0 mM, 1 mM, 5 mM and 10 mM). For 
each survival experiment, at least 2 vials, each containing 50 larvae, 
were maintained until fly eclosion. The number of eclosed flies was 
recorded. 
4.14. Immunohistochemistry and NMJ analysis 
Third instar wandering larvae were dissected, fixed, antibody 
stained, imaged and analysed as described previously [13]. All NMJ 
analysis was performed double-blind. Primary antibodies detailed in 
Table 1. Confocal microscopy was performed using a Zeiss LSM 880 on 
an Axio Observer.Z1 invert confocal microscope (Zeiss). Z-stacked pro-
jections of NMJ’s and VNCs were obtained using a Plan Neofluar 
40x/0.75 NA oil objective. NMJ lengths were measured from stacked 
NMJ images using the NeuronJ plugin for ImageJ (National Institutes of 
Health) as described previously [13,54]. 
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